Yale University

Timing of initiation of antiretroviral drugs during tuberculosis therapy.

TitleTiming of initiation of antiretroviral drugs during tuberculosis therapy.
Publication TypeJournal Article
Year of Publication2010
AuthorsAbdool Karim, Salim S., Kogieleum Naidoo, Anneke Grobler, Nesri Padayatchi, Cheryl Baxter, Andrew Gray, Tanuja Gengiah, Gonasagrie Nair, Sheila Bamber, Aarthi Singh, Munira Khan, Jacqueline Pienaar, Wafaa El-Sadr, Gerald Friedland, and Quarraisha Abdool Karim
JournalThe New England journal of medicine
Date Published2010 Feb 25
KeywordsAdult, AIDS-Related Opportunistic Infections, Anti-Retroviral Agents, Antitubercular Agents, CD4 Lymphocyte Count, Drug Administration Schedule, Drug Therapy, Combination, Female, Follow-Up Studies, HIV, HIV Infections, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Patient Compliance, RNA, Viral, Tuberculosis, Viral Load, Young Adult
AbstractThe rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial.
Alternate JournalN. Engl. J. Med.

External Links